Philips Medical Solutions wants operators of its MR scanners to work smarter, not harder. To help, the company developed SmartExam.
Philips Medical Solutions wants operators of its MR scanners to work smarter, not harder. To help, the company developed SmartExam.
Technology unveiled at the RSNA meeting in December automates the planning, scanning, and processing of MR scans. This decreases overall exam time, while increasing consistency and reliability, according to the company. The algorithm runs on all Philips MR systems.
The process begins with settings stored in Philips' ExamCards, which are customized for individual exams. SmartExam automatically detects anatomic landmarks in a survey scan of the patient, then plans the diagnostic scans related to the patient's actual position in the magnet.
The operator defines the spatial resolution, and SmartExam does the rest, according to Philips, automatically maintaining resolution and image contrast regardless of variations in the field-of-view.
Other MR enhancements shown at the Philips booth include diffusion body scanning, which is designed to improve detection of lesions throughout the body. 4D-TRAK MR Angiography (4D time-resolved angiography using keyhole) makes MR angiography up to 60 times faster. It allows the visualization, for example, of feeding and draining arteries and veins in arteriovenous malformations.
FiberTrak visualizes white matter fibers in the brain, providing a map that neurosurgeons can use to avoid or minimize damage to the neurologic pathways that control speech and movement. Another feature, k-t BLAST, boosts the speed of cardiac MR by a factor of five, reducing scan times for the heart and making cine cardiac MRI in a single breath-hold a reality.
Can MRI-Based AI Enhance Pre-Op Prediction of Tumor Deposits in Patients with Rectal Cancer?
October 31st 2024For patients with rectal cancer, an emerging nomogram that combines deep learning and clinical factors had greater than 16 percent and 23 percent increases in accuracy and specificity, respectively, for pre-op prediction of tumor deposits in comparison to clinical factors alone.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.